Kovitz Investment Group Partners LLC bought a new position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 263,671 shares of the company's stock, valued at approximately $4,878,000. Kovitz Investment Group Partners LLC owned about 0.71% of Crescent Capital BDC at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the company. HighTower Advisors LLC increased its stake in shares of Crescent Capital BDC by 0.5% in the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock valued at $2,624,000 after acquiring an additional 768 shares in the last quarter. Confluence Investment Management LLC boosted its stake in shares of Crescent Capital BDC by 2.2% during the third quarter. Confluence Investment Management LLC now owns 73,206 shares of the company's stock valued at $1,354,000 after purchasing an additional 1,583 shares during the period. Point72 Asset Management L.P. bought a new position in Crescent Capital BDC in the second quarter worth $90,000. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Crescent Capital BDC by 14.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company's stock worth $1,517,000 after purchasing an additional 10,000 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of Crescent Capital BDC in the 2nd quarter worth $195,000. Institutional investors and hedge funds own 49.46% of the company's stock.
Wall Street Analyst Weigh In
CCAP has been the topic of several research analyst reports. Keefe, Bruyette & Woods boosted their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Monday, November 25th. LADENBURG THALM/SH SH began coverage on Crescent Capital BDC in a research note on Monday, September 30th. They issued a "buy" rating and a $20.00 target price on the stock. Bank of America dropped their price target on Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating on the stock in a research note on Thursday, August 15th. Finally, Wells Fargo & Company decreased their price target on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a report on Wednesday, August 14th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $19.17.
View Our Latest Stock Report on Crescent Capital BDC
Crescent Capital BDC Trading Up 1.0 %
CCAP stock traded up $0.20 during trading on Monday, reaching $19.67. 143,905 shares of the stock traded hands, compared to its average volume of 129,733. The business's 50 day moving average price is $18.64 and its 200-day moving average price is $18.59. Crescent Capital BDC, Inc. has a 52-week low of $15.91 and a 52-week high of $19.69. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The firm has a market capitalization of $728.97 million, a PE ratio of 7.71 and a beta of 0.82.
Crescent Capital BDC Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be paid a $0.42 dividend. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.07. The ex-dividend date is Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 8.54%. Crescent Capital BDC's payout ratio is 65.88%.
Crescent Capital BDC Company Profile
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Read More
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.